Success Stories: In Less Than 5 Months NIW Approval Received for Director of Surgery Research in Dermatology from Canada, thanks to Our Team of Experts
Client’s Testimonial:
“I have had a fantastic experience with Chen Immigration Team! They were very knowledgeable and were present at every step of the way to support and guide me. Even though I did not think that I would get approval in 4 months, it happened and I couldn’t be happier. Thank you so much Chen Immigration Team!!!”
On March 23rd, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Director of Surgery Research in the Field of Dermatology (Approval Notice).
General Field: Dermatology
Position at the Time of Case Filing: Director of Surgery Research
Country of Origin: Canada
Country of Residence at the Time of Filing: Canada
Approval Notice Date: March 23rd, 2022
Processing Time: 4 months, 19 days
Case Summary:
As an expert in the field of dermatology, our NIW (National Interest Waiver) client from Canada had a proposed endeavor to examine new techniques in dermatology. She wanted to improve the efficacy and safety of dermatologic surgical methods and clinical trials, advance knowledge about publication bias and enhance large-scale dermatology education initiatives, ultimately improving clinical outcomes. It was apparent that her research is of great importance because it improves dermatology practice and research on a variety of levels.
Our team after some background check found that all of her research efforts contribute to improving the rates of early detection and treatment of skin cancer, be it through improving the baseline dermatological education all medical students receive, increased standardization of surgical guidelines, or more transparency in clinical trial reporting. This is why one of her 5 recommenders said:
“[The client’s] record of completing important research has established her position of expertise in the field of dermatology. Her research on mitigating the under-education of dermatology among medical professionals has led to significant advancements in both the academic pursuit of dermatology and its practice. [Client’s] efforts to instate case-based learning and large-scale patient viewing programs in dermatology education are unparalleled. Because of this, it is of chief importance to the United States that [the client] be allowed to conduct her work here due to the inherent value of her research and commitment to improving medical education.”
Not only this, but due to her expertise and record of success, we showed she is also considered a leader in the field of dermatology. She has served as a committee executive at the 2017 Atlantic Dermatology Conference. In addition, she is a dermatologist member of the Dermatologists Reaching for Excellence and Achievement in the Practice of Medicine, which are both professional associations to which one must be nominated.
In addition to these achievements, her research has resulted in 17 peer-reviewed journal articles (14 of them first-authored), and she has also published one book chapter and one booklet. These publications have been cited a total of 68 times according to Google Scholar. In recognition of the value and importance of her work, it has been granted funding by the Canadian Institutes of Health Research (CIHR) Dissemination Events, and The Academy of Finland. She has also been invited to present at various national and international conferences in her field.
These publications in authoritative journals and presentations at elite conferences serve as clear evidence of her recognized expertise in dermatology and ensured that her advances related to improving new dermatologic surgery techniques and expanding the accessibility and efficacy of dermatology education have reached a broad international audience. We thus showcased her talent and proved that she is indeed eligible for and otherwise merits a national interest waiver. So when we got her approval we were glad to have been a part of her success story. Our firm wishes her good luck in her future endeavors.